Aquestive Therapeutics Inc. (AQST) announced Loss for its fourth quarter of -$17.06 million
The company's bottom line totaled -$17.06 million, or -$0.19 per share. This compares with -$8.11 million, or -$0.12 per share, last year.
The company's revenue for the period fell 10.1% to $11.87 million from $13.21 million last year.
Aquestive Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$17.06 Mln. vs. -$8.11 Mln. last year.
-EPS: -$0.19 vs. -$0.12 last year.
-Revenue: $11.87 Mln vs. $13.21 Mln last year.
For comments and feedback: editorial@rttnews.com